Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS
| Image |  |
|---|---|
| Description | scientific article published on 19 October 2011 |
| Author/s |
author: Remy Gressin Mario Ojeda-uribe |
| Publication date | October 19, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |